SCNI
SCINAI Ends PC111 Arrangements to Refocus on NanoAb and CDMO Work
Scinai says it has concluded its PC111 arrangements and will redirect capital to its NanoAb platform and expanding CDMO business.
REDFILED Newsdesk
News from SEC filings, FDA decisions and company releases, drafted with AI and checked by an editor before publication. How we work: redfiled.com/how-we-work/
GSK
GSK Files Q2 Report Showing £8.4bn Sales and £1.9bn Savings Plan
GSK's 6-K restates second-quarter 2026 turnover of £8.4 billion, up 5%, alongside a three-year Accelerate Growth programme targeting £1.9 billion in annual savings by 2029.
GFS
GLOBALFOUNDRIES Finalizes $375M CHIPS Award for Quantum Chip R&D
The chipmaker signed a definitive agreement with the Commerce Department for up to $375 million over five years to scale its Quantum Technology Solutions business.
VERU
VERU Pushes Oral Sabizabulin Into Phase 2 for Daraxonrasib-Resistant Pancreatic Cancer
Veru will seek an FDA pre-IND meeting in Q4 2026 after preclinical data showed sabizabulin remains potent in daraxonrasib-resistant pancreatic cancer cells.
VERU
VERU Pivots Sabizabulin to Pancreatic Cancer After Preclinical Data
Veru will take oral sabizabulin into a planned Phase 2b trial in daraxonrasib-resistant pancreatic cancer and drops its cardiovascular inflammation plan.
CANF
CAN-FITE Sees Longer-Than-Expected Survival in Phase III Liver Cancer Trial
Israeli biotech reports a $4.6 million half-year loss and says blinded survival in its pivotal Namodenoson HCC study is running longer than assumed.
SOLB
SOLVAY Confirms Talks With OneIM Over Rare Earths Partnership
The Belgian chemicals group says discussions with One Investment Management on a strategic partnership for its rare earths unit are ongoing, with no certainty of a deal.
ABAT
AMERICAN BATTERY TECHNOLOGY Clears BLM Hurdle for Tonopah Flats Lithium
The Bureau of Land Management accepted the mine and refinery Plan of Operations for ABTC's Nevada lithium project, moving it into environmental review.
GFS
GLOBALFOUNDRIES to Issue 9.9M Shares to U.S. Commerce Department
GlobalFoundries will hand the Commerce Department nearly 9.91 million ordinary shares at $37.85 apiece, a stake worth roughly $375 million.
DFTX
FDA Grants DEFINIUM Second Breakthrough Therapy Tag for LSD Tablet
Definium's DT120 gets Breakthrough Therapy designation in major depressive disorder after a Phase 3 win, adding to an earlier tag in generalized anxiety.
GME
GAMESTOP Lifts FY26 EBITDA Outlook as Collectibles Jump 57%
GameStop posted record second-quarter operating income of $160.2 million and raised its full-year adjusted EBITDA outlook to more than $650 million.
GRI
GRI BIO Presents Phase 2a Biomarker Data on GRI-0621 in IPF at ERS 2026
New translational data from the 35-patient Phase 2a study point to a repair phenotype, with placebo-adjusted FVC of +99 mL at Week 12 and no serious drug-related events.